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 In recent years, applications of nanotechnology have increased at an 
unprecedented rate.  Nanotechnology, which is the engineering of matter on an atomic 
and molecular scale, has proven beneficial in a number of scientific fields.  In particular, 
nanotechnology has been credited with the use of nanoparticles for drug delivery and 
select nanomaterials have proven especially advantageous due to their highly variable 
functionalities and nontoxic nature 1.
 Nanoparticles are characterized as being 1 to 100 nanometers in size, and are of 
great medical importance due to their unique characteristics.  Each nanoparticle maintains 
a surface to mass ratio that is much larger than that of other particles.  This allows 
compounds such as drugs, probes and proteins to bind to its surface.  The nanoparticle is 
then able to carry the adsorbed substance throughout the body.  Though it is certain that 
interaction occurs between nanoparticles and plasma proteins within the body, the extent 
to which they interact remains a matter of debate 2.
 In this particular study the aim is to examine the role of plasma proteins in the 
cellular uptake of metallic nanoparticles.  It is proposed that cellular uptake is 
predominantly driven by the presence of plasma protein; as such, increased uptake or 
adsorption is expected in the presence of a nanoparticle-plasma protein complex.  
Examination of plasma proteins and their effects on the cellular uptake of nanoparticles 
will, in turn, advance the use and applications of nanomaterials.
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CHAPTER I
NANOTECHNOLOGY: BACKGROUND AND SIGNIFICANCE
 
 The use of nanomaterials, including nanoparticles in medicine and industrial 
products, has exponentially increased over the past few years.  According to the National 
Institute of Health, the global demand for nanomaterials and nano-enabled devices is 
expected to exceed $3.1 trillion by 2015.  This branch of technology, which is confined to 
materials having nanoscale features, has peeked interests and investments in research and 
development (R&D) (Figure 1).  In fact, nanotechnology—more so than any other 
technological field—has benefitted from substantial R&D investments, both public and 
through the private sector 3 (Figure 2) .
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Figure 1. Public R&D Investments in Nanotechnology Globally  3
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 Figure 2. Structure of R&D Investments in the U.S., European Union (E.U.), and 
 Japan by Institutional Sector, 2004-06 4
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 Investments in nanotechnology are further classified according to sub-area and 
patent data, the latter providing insight into the development and potential pathway of the 
field.  The distribution of patents by field is outlined in Figure 3.  Of the 
nanotechnological patents identified, the largest share is held by the nanomaterials sub-
area—a division of particular interest in materials science.!"#$%!&'()**+,-.
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CHAPTER II
NANOMATERIAL OF INTEREST: COLLOIDAL GOLD NANOPARTICLES
! Gold nanoparticles (Au-NPs), which exist as a colloidal suspension, are 
nanometer-sized particles of gold.  This nanomaterial has been used since 753 B.C.—
initially for the purpose of glass staining 6.  It was not until the nineteenth century that 
colloidal gold was investigated for its scientific properties by Michael Faraday, at which 
time Au-NPs were discovered to have properties differing from bulk gold 7.
!
! Further characterizing colloidal gold solutions, each was found to differ in hue 
according to the diameter of its suspended particles (Figure 4); solutions containing 
particles of 100 nm or less maintain an intense red color while those having diameters 
greater than 100 nm appear yellow.  By taking advantage of variant nanoparticle sizes 
and their intrinsic interactions with light, each colloidal suspension can be tailored 
according to its optical properties and used in a number of applications. 8
4
Figure 4. Aqueous Solutions of Gold Nanospheres as a Function of Increasing 
Dimensions 8
! Owing to their unique optical properties, Au-NPs maintain applicability in a 
number of disciplines including biological imaging, electronics and materials science.    
These optical properties can be tuned and used to treat and diagnose disease in either an 
indirect or direct manner.  Furthermore, colloidal gold solutions can be tailored into 
various sizes, shapes and decorations, thereby affecting their functionality.  This intrinsic 
characteristic has proven beneficial in biomedical applications, particularly targeted drug 
delivery systems (TDDS). 9
!
5
! Synthesis methods for Au-NPs were reported as early as 1951 by Dr. Turkevich 
who developed a 13 nm pivot synthesis, making way for current one-pot synthesis 
techniques.  Facilitated one-pot synthesis procedures have led to the formation of 
nanoparticles ranging from 0.8 nm to 200 nm, the smallest of which have been shown to 
penetrate into cell nuclei and cross the blood brain barrier 9.  Ultra-fine nanoparticles 
have too been shown to bind various agents, probes and drugs, thereby serving as an 
effective delivery system for the treatment of cancerous cells and the like. 
Colloidal Gold and Zeta Potential
! Zeta potential (") refers to the electrokinetic potential of a colloidal system and is 
quantified by the electric potential in the interfacial double layer of the colloid.  A "-
potential schematic for colloidal gold is shown in Figure 5. 
6
Figure 5.  Zeta Potential Schematic of Colloidal Gold 10
!
! The double layer (DL) is comprised of two parallel layers of charge that surround 
the Au-NP.  The first layer, or layer of charge that immediately surrounds the 
nanoparticle, is deemed the surface charge.  It is made up of ions that are directly 
adsorbed onto the surface of the nanoparticle as a result of various chemical interactions. 
7
! The second layer maintains a detached attraction to the nanoparticle, as it is 
comprised of ions that are fluid, operating in accordance with electrical attraction and 
thermal motion.  The "-potential is therein described by the electric potential in this 
interfacial double layer at the slipping plane versus a given point in the bulk fluid—the 
potential difference between the colloidal suspension of the Au-NP and the layer of fluid 
directly interacting with the particle defines the zeta potential.
!
! Zeta potential values are used to classify the nature of colloidal suspensions, with 
a high "-potential—of magnitude 25 mV or more—indicative of stability and aggregative 
resistance (Figures 6 & 7).
8
Connect your Facebook account to check out what your friends are sharing on SlideShare Connect !
SlideShare
Submit Search…
Upload
Go Pro
Login
Signup
Browse  
   Email Like Save Embed
1
« ‹ › »
  /30
Like
Like
Like
Like
Like
More
! ! !
Figure 6. Zeta Potential and Stability 10
Zeta potential
Zeta potential is a scientific term for electroki-
netic potential[1] in colloidal systems. In the
colloidal chemistry literature, it is usually de-
noted using the Greek letter zeta, hence !-
potential. From a theoretical viewpoint, the
zeta potential is the electric potential in the in-
terfacial double layer (DL) at the location of
the slipping plane versus a point in the bulk
fluid away from the interface. In other words,
zeta potential is the potential difference be-
tween the dispersion medium and the station-
ary layer of fluid attached to the dispersed particle.
A value of 25 mV (positive or negative) can be taken as the arbitrary value that sepa-
rates low-charged surfaces from highly-charged surfaces.
The significance of zeta potential is that its value can be related to the stability of col-
loidal dispersions (e.g., a multivitamin syrup). The zeta potential indicates the degree of
repulsion between adjacent, similarly charged particles (the vitamins) in a dispersion.
For molecules and particles that are small enough, a high zeta potential will confer
stability, i.e., the solution or dispersion will resist aggregation. When the potential is
low, attraction exceeds repulsion and the dispersion will break and flocculate. So, col-
loids with high zeta potential (negative or positive) are electrically stabilized while col-
loids with low zeta potentials tend to coagulate or flocculate as outlined in the table.[2][3]
Zeta potential [mV] Stability behavior of the colloid
from 0 to ±5, Rapid coagulation or flocculation
from ±10 to ±30 Incipient instability
from ±30 to ±40 Moderate stability
from ±40 to ±60 Good stability
more than ±61 Excellent stability
Zeta potential is widely used for quantification of the magnitude of the electrical charge
at the double layer. However, zeta potential is not equal to the Stern potential or electric
surface potential in the double layer.[4] Such assumptions of equality should be applied
with caution. Nevertheless, zeta potential is often the only available path for characteri-
  Figure 7. Zeta Potential and Stability 10
 Zeta potential reference measurements were performed by the National Institute 
of Standards and Technology (NIST) for 10 nm, 30 nm and 60 nm Au-NPs.  Results 
indicate that 30 nm and 60 nm particles maintain "-potential values of -33 +/- 6.9 and 
-37.6 +/- 3.0, respectively 11.  Due to the intrinsically nanosized features of 10 nm Au-
NPs, alongside their tendency to aggregate in solution, no "-potential value was 
definitively characterized.
!
9
! Zeta potential, which is described according to the nature of a nanoparticle’s 
surface charge and its surrounding solution, becomes increasingly complex to quantify in 
the presence of protein molecules.  Protein molecule surface charges consist of unevenly 
distributed and complicated functions of amino acids and residues.  Moreover, these 
charges are highly dependent upon the surrounding medium of the protein.  In select 
modeling systems the interaction of proteins with charged surfaces has been shown to 
induce charge upon the protein molecule itself 2.  Adsorption studies of bovine serum 
albumin (BSA), a protein molecule of particular interest in this investigation, indicate 
changes in zeta potential—particularly at the protein’s isoelectric point.  Toward this end, 
interactions had by colloidal gold solutions and plasma proteins present an incredibly 
complex system as related to charge distribution. 
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CHAPTER III
PLASMA PROTEIN OF INTEREST: BOVINE SERUM ALBUMIN
!
! Bovine Serum Albumin (BSA) is a large globular protein having a molecular 
weight of 66.5 kDa.  It is regarded as a very functional protein, readily binding fatty acids 
and other lipids.  This macromolecule is reported to partially unfold between 40 - 50 ˚C, 
thereby exposing its surface layer non-polar residues and enabling reversible protein-
protein interactions 12.  BSA, one of the most widely used plasma proteins in research, is 
commonly added to solutions in order to stabilize enzymatic reactivity.  Owing to its 
relatively neutral characteristics, BSA does not interfere with the enzyme of interest.  
!
! Albumin proteins are known to be amongst the smallest and most abundant 
plasma proteins within blood, indicative of the many metabolic compounds and 
therapeutic drugs for which they are responsible in transporting.  These plasma proteins 
maintain a very high stability at select pH ranges (4-9) and below 60 ˚C.  Furthermore, 
these proteins have demonstrated preferential uptake in tumor and inflamed tissue, 
biodegradability, low toxicity, immunogenicity and, with a half-life of 19 days, prove to 
effectively circulate within the blood  13.  Albumin proteins exhibit high binding 
capacities as a result of multiple drug binding sites and, as such, have been deemed an 
ideal drug carrier.
11
! ! Figure 8. Bovine Serum Albumin, Crystal Structure 14
! Globular proteins, as is BSA (Figure 8), retain their structure in the presence of 
particles having increased surface curvature 2.  Surface curvature, which is an inherent 
property of nanosized particles, increases with decreasing particle size.  A recent 
molecular interactions study of proteins and nanoparticles proposed information 
concerning the adsorption of BSA to Au-NPs.  In this investigation BSA was adsorbed to 
the surface of hydrophilic Au-NPs, ranging 10 - 20 nm in diameter.  In each case BSA 
was shown to retain its native-like structure.  In alternate studies, however, the adsorption 
of biological molecules onto the surface of nano-structures yielded dissimilar results.  
12
Under identical conditions and particle diameters, the secondary structure of proteins was 
disturbed, resulting in aggregation of the protein molecule.  In turn, the nano-bio interface 
is regarded as an elaborate arrangement and heavily investigated in terms of its molecular 
dynamics.
13
CHAPTER IV
THE NANOPARTICLE-PROTEIN INTERFACE
 Nanoparticle-protein conjugates (Figure 9) maintain applicability in sensing, self-
assembly and imaging techniques.  Their usefulness in these types of applications, 
however, is dependent upon the site-specific adhesion of protein to the nanoparticle of 
interest.  Binding should occur in a way so as not to interfere with the structure nor 
function of the protein.  This is difficult to achieve.  Both nanoparticles and proteins are 
incredibly complex chemical systems and interact by way of numerous non-covalent 
interactions.  As a result, the nanoparticle-protein interface is not well understood and is a 
major barrier in terms of biological applications. 15
14
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Figure 9. Nanoparticle-Protein Interface 15
The Nanoparticle-Protein Corona Theory
 
 While the nature of the nanoparticle-protein interface is yet to be fully understood, 
it is increasingly accepted that the surface of nanoparticles—in biological environments
—is modified by the adsorption of biomolecules, namely proteins and lipids 16.   This 
biomolecular interface is characterized as either a hard or soft protein corona (Figure 10), 
each category indicative of nanoparticle-protein adhesion rates.  The lifetime of the hard 
protein corona is believed to be for many hours and stable enough to govern the 
biological identity of the nanoparticle to which it is adsorbed.  
 
15
 In a typical biological environment, there are a number of biomolecules 
competing for adsorption to a limited nanoparticle surface.  Thus, the nanoparticle-
protein corona is dependent upon the ratio of available nanoparticle surface area to 
surrounding proteins 16.  In biological solutions the most abundant protein is immediately 
bound to the nanoparticle and later ejected from the corona to be replaced by proteins 
having a higher affinity for the nanoparticle.  The identity of the corona is, in turn, 
dictated by protein-binding affinities and the intrinsic properties of the associated 
nanoparticle.
 
 A study of the corona within varied biological environments points toward an 
evolution of the nanoparticle-protein corona (Figure 10) and its adaptive nature.  The 
long-lived or “hard” corona is shown to re-equilibrate as the nanoparticle moves from 
one biological fluid to another.  Within the second biological solution, the protein corona 
maintains a fingerprint of its history—though some proteins, having been initially 
adsorbed to the nanoparticle, are replaced by those in the new biological fluid a number 
of proteins in the original corona remain. 17
16
Figure 10.  Evolution of the Nanoparticle-Protein Corona 17
 Although a direct comparison cannot be drawn in terms of the cellular uptake 
pathway, the nanoparticle-protein corona theory has major implications: 1) in a given 
biological solution nanoparticle-protein complexes form in a transient yet specific 
manner and 2) the nanoparticle-protein corona, if sufficiently long-lived, comes to dictate 
the biological fate of nanoparticles.
17
CHAPTER V
NANOPARTICLES AND CELLULAR UPTAKE
 As nanoparticle applications continue to increase, as does the potential for 
incidental exposure and deliberate contact through targeted delivery systems and products 
18.  Even with expanding interest in the field, the potential effects of nanoparticles on 
cellular systems and their resultant toxicity remains under investigated.  Effects of 
nanoparticle exposure are dependent upon a number of quantifiable parameters—
including cell type, nanoparticle dosage, composition, size, shape and surface chemistry
—yet minimal studies have been performed that mathematically model or directly 
investigate the cellular uptake of nanoparticles.  Though considerable work has been done 
in the quantitative analysis of cellular uptake and nanoparticles, elucidation of a pathway 
remains incomplete.  
 
 As such, no definitive models have been presented but rather a number of 
potential entry mechanisms (Figure 12).  These include: 1) endocytosis, 2) diffusion and 
3) channel, all of which are thought to occur by way of a nanoparticle-lipid bilayer 
interface (Figure 11).
18
 
Figure 1. Representation of the interface 
between a nanoparticle and a lipid bilayer. 
(Figure and legend taken from Reference 3) 
 
Figure 2. Potential mechanisms of nanoparticle entry into cells. 
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Summary: The ever increasing production and use of manufactured nanoparticles in industry, 
research and medicine, has led to greater potential for incidental environmental exposure, as 
well as deliberate contact through products and therapeutics (1).  However, the potential for 
cellular entry and toxicity of manufactured nanoparticles has only recently begun to be 
investigated.  The extent of potential cellular affects following nanoparticle exposure would 
depend upon environmental conditions, cell type, nanoparticle dosage, composition, size, 
shape and surface chemistry.  However, very little work in the field of mathematical modelling 
has been focused on the question of how manufactured nanoparticles enter cells.  That being 
said, within each potential mechanism for cellular entry of nanoparticles there has been 
considerable quantitative analysis of the relevant pathways.  Therefore, this represents a 
 which 
no comparable overall models have been generated thus far. 
Potential mechanisms of entry:  The cell is bound by the plasma membrane, a lipid bilayer 
which contains opposing monolayers, or leaflets, of phospholipids with the hydrophilic head 
groups facing the extracellular and intracellular solutions, and the hydrophobic tails facing 
each other (Figure 1).  Generally speaking three 
routes for nanoparticle entry into cells exist, each 
of which must be analysed independently before a 
comprehensive model can be formed (Figure 2). 
Mechanism 1: Direct diffusion of nanoparticles 
across the plasma membrane can occur and has 
been described in certain situations (2).  Numerous 
variables could affect the ability of a nanoparticle to 
penetrate the lipid bilayer including size, charge, 
hydrophobicity, composition and shape.  
Furthermore, these parameters need to be 
considered within the different physical spaces 
involved, including the nanoparticle surface, the 
solid-liquid interface, and the nano-bio interface 
(3).  This analysis would also need to include 
characterisation of the biological membrane 
including the lipid composition, fluidity and 
identities of membrane bound molecular species.  
Importantly, some molecular 
dynamic simulations have 
already been generated to 
describe the potential diffusion 
of specific types of nanoparticles 
across biological membranes 
which could serve as a very 
useful starting point in further 
modelling of this process (4). 
Description for a problem studied at the UK Mathematics-in-Medicine Study Group Reading 2011
< http://www.maths-in-medicine.org/uk/2011/nanoparticles/ >
Figure 11. Nanoparticle and Lipid Bilayer Interface 19
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Fi re 1   tential Mechanisms of Nanoparticle Cellular Uptake 18
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1) Diffusion
 The direct diffusion of nanoparticles across the cellular membrane is thought to 
occur in select pathways.  This penetration of the lipid bilayer is, however, dependent 
upon a number of variables with regard to the nanoparticle of interest.  The size, charge, 
hydrophobicity, composition and shape of a nanoparticle are believed to dictate the 
mechanism of uptake and, furthermore, depends upon the medium involved.  The 
nanoparticle surface, solid-liquid interface and nano-bio interface (each of which is 
shown in Figure 11) characterize the biological environment and resulting behaviors. 18
2) Endocytosis
 Endocytosis refers to the engulfment of a particle within the lipid bilayer.  This 
process is most often used to ingest very large or polar molecules that do not readily 
travel through hydrophobic medium or the cell membrane.  Data suggests that the 
endocytosis pathway varies according to nanoparticle size and other such physical 
parameters. 19
3) Channel 
 Though a number of ion channels and transporter proteins are contained within 
the plasma protein, they maintain a high level of selectivity and incredibly small pore 
sizes.  In theory, these channels assist in the translocation of substances into and out of 
the cell.  Each pore is aqueous and facilitates the rapid movement of molecules across the 
20
cellular membrane.  As is the case, only nanoparticles having extremely small or 
negligible diameters are thought to proceed by way of ion channels. 22
21
CHAPTER VI
HYPOTHESIS AND SPECIFIC AIM
! We propose that the cellular uptake of nanoparticles is, in some way, mediated by 
the presence of plasma protein.  As such, our aim is to examine differences in cellular 
uptake between bare Au-NPs and plasma protein coated Au-NPs.  In this study 10 nm Au-
NPs will be used to form nanoparticle-plasma protein complexes with the commercially 
available bovine serum albumin protein (BSA).  A representative schematic of our 
proposed investigation is pictured in Figure 13.
BSA Cellular Uptake
Bare Au-NP
Target Cell
BSA Coated Au-NP
Figure 13. Examination of Protein-Coated Au-NP Cellular Uptake
! It should be noted that, to date, there is no standard method with which to follow 
the cellular uptake of nanoparticles.  As such, this study does not propose to lend 
22
information pertaining to the mechanism of nanoparticle cellular entry but rather the role 
of plasma protein in the cellular uptake of Au-NPs.
Experimental Outline
Investigation of Au-NP cellular uptake will proceed in three stages:
1) Host Cell Formation and Lysis
2) Nanoparticle-Protein Complexation
3) Examination of Cellular Uptake
23
CHAPTER VII
HOST CELL FORMATION AND LYSIS
Objective - Host Cell Formation
 
 For the purposes of this study, the Cytochrome P450 BMH-F87G: W96H cell line 
was acquired to use as a host for Au-NP delivery.  This cell line contains a double-
mutated plasmid obtained by way of a single mutation of the Trp96 codon on a 
previously mutated F87G plasmid that screened positive for the mutation 23.  The cell line 
is further characterized as a gram-negative Escherichia coli bacterial strain.  It should be 
noted that bacterial versus mammalian cells were used in this study; bacterial cell lines 
are known to have less complex systems and greater reproducibility In vitro.
Experimental- Host Cell Formation
 Growing nutrient used for the bacterial cell line was prepared by dissolving 47.6 g 
of Terrific Broth Medium (TBM), available from Sigma Aldrich, in 1 L of NANOpure 
water.  The solution was then autoclaved in a Primus® system at 250 ˚F for a 16 minute 
sterilization time and then cooled to room temperature.  An aliquot of the broth was 
treated with ampicillin (1 mg/ mL) to prevent cell culture contamination.  Bacteria from 
the F87G cell line was added to the TBM aliquot at a dilution of 1.75 mL / 35 mL TBM.  
24
Cells were incubated in a rotary shaker at 37˚C  / 90 rpm and harvested at an optical 
density (OD) of 0.2 - 0.3, as measured by the Cary UV-Vis Spectrophotometer.
Experimental Results- Host Cell Formation
 
Figure 14. Cellular Growth of F87G Cells as a Function of Time
Objective - Lysis
 
 In order to quantify the cellular uptake of Au-NP content, lysing procedures for 
the F87G cell line were examined.  Noting the sensitivity of select nanoparticles, a non-
chemical disruption technique was first explored, followed by a chemical digestion 
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approach.  It should be noted that the Au-NPs used in this study were not compromised 
by chemical disruption methods.  
 
 Through both the chemical (nitric acid digestion) and non-chemical (sonication) 
lysing techniques employed, the aim was to disrupt the cells and to recover a maximal 
amount of cellular content.  The lysate from each cellular sample would then be used to 
quantify the amount of Au-NPs ingested by F87G cells. 
 
 Results from the non-chemical digestion method are displayed in Figures 15 & 16 
and discussed in detail in Chapter XI.
Experimental - Lysis
 Three milliliters of cellular content were transferred to a 10 mL centrifuge tube 
and inserted into the Ultrasonic 3000 Homogenizer instrument.  Instrument settings were 
varied according to pulsing speed, intensity and time (pulsing time did not exceed 5 min. 
in order to preserve cellular integrity).  In order to determine cellular disruption 
percentage values, an initial OD measurement was recorded prior to sonication and a 
second OD value recorded following cellular disruption.
26
Experimental Results- Lysis
 Figure 15. Percent of Cellular Disruption as a Function of Pulsing Speed
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 Figure 16. Percent of Cellular Disruption as a Function of Pulsing Time
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CHAPTER VIII
NANOPARTICLE-PROTEIN COMPLEXATION
Summary of Results
 
 According to work performed by researchers Lynch and Dawson, nanoparticles 
and proteins—when introduced into a biological environment—form a nanoparticle-
protein complex 16.  As such, the complexation of Au-NP and protein was not further 
investigated in this study.
 
 For the purposes of quantifying nanoparticle and protein complexation as related 
to experimental parameters, Au-NP and BSA were combined in solution.  Following 
attempts to quantify the presence of Au-NP within the complex, our method of 
instrumentation (UV-Vis Spectrometry) proved inefficient—this technique was not 
sensitive enough to account for the intrinsic concentration of Au-NP being used.  In turn, 
this portion of the study led to the examination of alternate methodology, at which time 
the Au-NP content within nanoparticle-protein complexes was indirectly quantified by 
way of cellular uptake studies.
29
CHAPTER IX
GRAPHITE FURNACE ATOMIC ABSORPTION SPECTROMETRY
 
 Owing to the noted lack of sensitivity within UV-Vis Spectrometry techniques, 
alternate instrumentation was examined for its viability in measuring the presence of Au-
NP content within cells.  Considered methodologies included: 1) immunoassays, which 
posed an extensive effort in the location of appropriate antigen and antibody 
combinations, 2) mass spectrometry, also proving lengthy in regard to training and 
acquiring technical skill and 3) zeta potential, known for the characterization of colloidal 
solutions yet not an available departmental resource.  The use of graphite furnace atomic 
absorption spectrometry (GFAAS), though not a standard way to measure the cellular 
uptake of colloidal gold, proved to be the most direct and readily available technique.
Background and Advantages
 GFAAS is a form of spectrometry that utilizes a graphite-coated furnace to 
atomize sample contents.  Atoms within the sample absorb light at wavelengths 
characteristic to the element of interest and, using this information, the concentration of 
analyte can be determined.  These concentration measurements are determined by way of 
an internal calibration curve, as generated by the instrument prior to sampling.
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 The GFAAS technique is inherently more sensitive than that of UV-Vis 
Spectrometry, has greater detection limits, low spectral interference and requires a 
reduced quantity of sample.
Instrumentation
 The GFAAS system used within this study was composed of the following basic 
features 1) an optimized Au lamp, which served as the source of light, 2) a graphite tube / 
atomization chamber wherein the sample is vaporized 3) a monochromator which selects 
for characteristic wavelengths of elemental Au, 4) a photo-multiplying detector and 5) a 
computing processor.
31
Figure 17. Graphite Furnace Atomic Absorption Spectrometer Schematic 24
 In order to achieve vaporization of the analyte, the GFAAS system operates 
according to a temperature programming system which gradually increases the furnace 
temperature with time.  Figure 18 diagrams the temperature programming of the 
SpectrAA 220 FS GFAAS system used within this study and optimized for the analysis of 
Au-NP cellular uptake.
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CHAPTER X
EXAMINATION OF CELLULAR UPTAKE
Phase I - 50 nm Au-NP Studies
 Objective
 In this phase of cellular uptake examination, we aimed to differentiate cellular 
uptake from the centrifugal sedimentation of Au-NPs in solution.  In doing so, we utilized 
our working knowledge of F87G cell centrifugation patterns.  In prior studies, cellular 
content was shown to be sufficiently collected at 6000 rpm / 10 min. / 4 ˚C.  In order to 
eliminate the possibility of Au-NPs being gravitationally depressed in solution versus 
ingested by cells, we sought to determine a centrifugation speed wherein Au-NPs 
remained suspended in solution while F87G cells were maximally collected.  
 Experimental
 A 50 nm colloidal gold solution was obtained from nanopartz.com.  It should be 
noted that 50 nm Au-NPs were first used for experimentation in order to develop a 
working knowledge of variant nanoparticle sizes in solution.  Performing initial studies 
with a median-sized nanoparticle allowed for facilitated adjustment within the 1 - 100 nm 
particle range.
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 Four milliliters of 1X Phosphate Buffer Saline (PBS) were transferred to a 15 mL 
centrifuge tube and combined with 0.2 mL of 50 nm Au-NPs.  This solution was gently 
inverted.  The optical density of the solution was measured by way of UV-Vis 
Spectrometry at 530 nm.  Solution contents were then centrifuged at conditions optimized 
for the collection of F87G cells.  The optical density of the supernatant was remeasured 
following centrifugation in order to detect for Au-NPs remaining in solution.
 
 Owing to the inherent lack of sensitivity yielded by UV-Vis Spectrometry 
measurements, these results were validated by way GFAAS.  Again using 50 nm Au-NPs, 
0.2 mL of colloidal gold solution was combined with 4.0 mL of PBS.  Two 50 uL aliquots 
of the aforementioned solution were removed and digested overnight in 69% 
TraceSELECT HNO3—a chemical digestion technique for Au-NPs validated in literature. 
Aliquot 1 was centrifuged at conditions optimized for the collection of F87G cells and  
Aliquot 2 was not centrifuged.  GFAAS measurements were performed in order to detect 
for Au-NPs remaining in solution.
35
 Experimental Results
Figure 19. Removal of 50 nm Au-NPs from Solution via Centrifugation - UV-Vis 
Spectrometry Data
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Figure 20. Removal of 50 nm Au-NPs from Solution via Centrifugation - GFAAS 
Spectrometry Data
Phase II - 10 nm Au-NP Studies
 Objective
 The objectives of the 10 nm Au-NP study are identical to those previously 
mentioned in Phase I (p.34).  Colloidal Au-NPs for this portion of the study were 
obtained from Sigma Aldrich.
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 Results from this study are diagramed in Figure 21 and discussed in detail in 
Chapter XI.
 
Experimental
 Fifteen milliliters of 1X PBS were transferred to a 50 mL centrifuge tube and 
combined with 8 mL of 10 nm Au-NPs.  This solution was gently inverted.  The optical 
density of the solution was measured by way of UV-Vis Spectrometry at 530 nm.  
Solution contents were then centrifuged at conditions optimized for the collection of 
F87G cells.  The optical density of the supernatant was remeasured following 
centifugation in order to detect for Au-NPs remaining in solution.
 
38
Experimental Results
Figure 21. Removal of 10 nm Au-NPs from Solution via Centrifugation - UV Vis 
Spectrometry Data
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Phase III - Examining the Cellular Uptake of Bare Au-NPs
 Objective
 Having determined optimal centrifugation conditions that would point toward the  
uptake of 10 nm Au-NPs into the F87G cell line, we moved into dosing studies.  F87G 
cells were dosed with varying amounts of 10 nm Au-NPs and their lysate examined in 
order to quantify the amount of Au-NP uptake.
 Results from this study are diagramed in Figures 22 & 23 and discussed in detail 
in Chapter XI.
 
 Experimental
 A stock solution of F87G cell culture was prepared by adding 1.75 mL of bacteria 
to 35 mL of TBM within a culture flask and incubated at 37 ˚C / 90 rpm.  Cells were 
harvested at an optical density of 0.2 - 0.3, just before the point of exponential bacterial 
growth (see Figure 14).  Following incubation, the cell culture was centrifuged at 6000 
rpm / 35 min. / 4 ˚C  in order to collect and remove debris from the cell culture.
 
 Immediately following centrifugation, the supernatant was removed from the 
sample and cells were resuspended with 35 mL of fresh TBM.  The optical density was 
again measured at this point to ensure that an OD of  0.2 - 0.3  was present following the 
collection of cells.  
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Five sampling flasks were prepared as outlined in Table 1.
Tube One Tube Two Tube Three Tube Four Tube Five
F87G Cells
Ampicilin
Au-NPs
TBM
Total 
Volume
5.0 mL 5.0 mL 5.0 mL 5.0 mL 5.0 mL
0.5 mL 0.5 mL 0.5 mL 0.5 mL 0.5 mL 
0 mL 0.125 mL 0.25 0.5 mL 1.00 mL
4.5 mL 4.375 mL 4.25 mL 4.0 mL 3.5 mL
10 mL 10 mL 10 mL 10 mL 10 mL
Table 1. Dosage Levels of Bare 10 nm Au-NPs
 Each sampling flask was incubated at 37 ˚C / 90 rpm for 24 hours.  Following the 
24-hour incubation period samples were transferred into separate 25 mL centrifuge tubes 
and placed in an ice bath in preparation for centrifugation.  Cells were centrifuged at 
6000 rpm / 4 ˚C /10 min. in order to collect cellular content.
 The supernatant of each sample was removed with care so as not to disrupt the 
cellular pellet.  Three milliliters of cold 1X PBS were added to each sample in the same 
manner.  The addition of PBS aliquots was repeated twice in order to wash each sample a 
total of three times.
41
 Cellular digestion of each sample was carried out using concentrated Nitric Acid 
(69% TraceSELECT grade from Fluka Analytical).  Three-hundred microliters of HNO3 
were added to each sample and digested overnight in a 60 ˚C sand-bath.  The following 
day,  2 uL of lysate was removed, diluted in 400 uL of HNO3 and analyzed via the 
GFAAS system.
 Experimental Results
Figure 22. GFAAS Internal Calibration, Au-Standard Solutions
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Figure 23. Cellular Uptake of Bare 10 nm Au-NPs by F87G Cell Line
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Phase IV - Examining the Cellular Uptake of Protein-Coated Au-NPs
 Objective
 In the final phase of cellular uptake studies, the aim was to examine cellular 
uptake differences as related to BSA coated 10 nm Au-NPs and to determine, if any, the 
role of plasma protein in the uptake of colloidal gold.
 Results from this study are diagramed in Figures 24 & 25 and discussed in detail 
in Chapter XI.
 Experimental
 A stock solution of F87G cell culture was prepared by adding 1.75 mL of bacteria 
to 35 mL of TBM within a culture flask and incubated at 37 ˚C / 90 rpm.  Cells were 
harvested at an optical density of 0.2 - 0.3, just before the point of exponential bacterial 
growth.  Following incubation, the cell culture was centrifuged at 6000 rpm for 35 
minutes at 4 ˚C  in order to collect and remove debris from the cells.
 
 Immediately following centrifugation, the supernatant was removed from the 
sample and cells were resuspended with 35 mL of fresh TBM.  The optical density was 
again measured at this point to ensure that an OD of  0.2 - 0.3  was present following the 
collection of cells. 
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 Diluent (NANOPure water), BSA protein and 10 nm Au-NPs were premixed in 
said order in order to allow for the complexation of nanoparticle and protein before 
dosing into the cells.  Each premixed solution was then added into individual sampling 
flasks according  to the molar ratios of BSA:Au-NP outlined in Table 2 and Table 3.  
Sample 1
(0:1)
Sample 2
( 1:1)
Sample 3
(5:1)
Sample 4
(125:1)
Sample 5
(625:1)
Sample 6
(3125:1)
Diluent
BSA*
Au-NPs
F87G Cells
Ampicillin
TBM
VOLtot
0.375 mL 0.025 mL 0.025 mL 0.025 mL 0.025 mL 0.025 mL
0 mL 0.35 mL 0.35 mL 0.35 mL 0.35 mL 0.35 mL
.125 mL 0.125 mL 0.125 mL 0.125 mL 0.125 mL 0.125 mL
5.0 mL 5.0 mL 5.0 mL 5.0 mL 5.0 mL 5.0 mL
0.5 mL 0.5 mL 0.5 mL 0.5 mL 0.5 mL 0.5 mL
4.0 mL 4.0 mL 4.0 mL 4.0 mL 4.0 mL 4.0 mL
10 mL 10 mL 10 mL 10 mL 10 mL 10 mL
Table 2. Dosage Levels of Protein Coated Au-NPs, BSA:Au-NP (x:1)
* BSA solutions for the nanoparticle-protein premix were separately formulated to reflect 
outlined BSA to Au-NP molar ratios.  Each premix solution was then brought to the same 
total volume of 0.5 mL.
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Sample 1
( 0:2)
Sample 2
(5:2)
Sample 3
(125:2)
Sample 4
(625:2)
Sample 5
(3125:2)
Diluent
BSA*
Au-NPs
F87G Cells
Ampicillin
TBM
VOLtot
0.250 mL 0.025 mL 0.025 mL 0.025 mL 0.025 mL
0 mL 0.35 mL 0.35 mL 0.35 mL 0.35 mL
0.250 mL 0.125 mL 0.125 mL 0.125 mL 0.125 mL
5.0 mL 5.0 mL 5.0 mL 5.0 mL 5.0 mL
0.5 mL 0.5 mL 0.5 mL 0.5 mL 0.5 mL
4.0 mL 4.0 mL 4.0 mL 4.0 mL 4.0 mL
10 mL 10 mL 10 mL 10 mL 10 mL
Table 3. Dosage Levels of Protein Coated Au-NPs, BSA:Au-NP (x:2)
* BSA solutions for the nanoparticle-protein premix were separately formulated to reflect 
outlined BSA to Au-NP molar ratios.  Each premix solution was then brought to the same 
total volume of 0.5 mL
 Each sampling flask was incubated at 37 ˚C / 90 rpm for 24 hours.  Following the 
24-hour incubation period samples were transferred into separate 25 mL centrifuge tubes 
and placed in an ice bath in preparation for centrifugation.  Cells were centrifuged at 
6000 rpm / 10 min. / 4˚C  in order to collect cellular content.
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 The supernatant of each sample was removed and the cellular content was 
resuspended using 3 mL of cold 1X PBS.  Three milliliter aliquots of PBS was added two 
additional times while also resuspending collected F87G cells.
 The cellular digestion of each sample was carried out using concentrated Nitric 
Acid (69% TraceSELECT grade from Fluka Analytical).  Three-hundred microliters of 
HNO3 was added to each sampling tube and digested overnight in a 60 ˚C sand-bath.  The 
following day, 2 uL of lysate was removed, diluted in 400 uL of HNO3 and analyzed via 
the GFAAS system.
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Experimental Results
Figure 24. GFAAS Internal Calibration, Au-Standard Solutions
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Figure 25. Cellular Uptake of BSA Coated 10 nm Au-NPs by F87G Cell Line
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CHAPTER XI
OVERALL IMPLICATIONS
Investigative Observations
 
 Host Cell Formation and Lysis
 The F87G cell line cultured and used as the host cell within this experiment 
proved to be a viable vehicle for the cellular uptake of 10 nm Au-NPs, as is shown in 
Figure 23.  Owing to the minimal disruption of F87G cells via sonication—we were only 
able to achieve a maximum 40% recovery of cellular lysate using homogenization 
techniques (Figures 15 & 16)—this cell line necessitates chemical digestion.  
 
 While the use of Nitric Acid digestion techniques proved efficient in the 
aforementioned experimental methods, it may present complications in the digestion of 
nanoparticles which require more sensitive / non-chemical lysing methods.  In such cases, 
it may be beneficial to first explore the viability of a non-chemical digestion procedure as 
investigated in this study.
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 Nanoparticle-Protein Complexation
 As previously noted, the complexation of nanoparticle and protein was not 
directly investigated within this study but rather confirmed through literature references.  
In attempts to quantify the presence of Au-NP in complexed solutions of nanoparticle and 
protein, UV-Vis Spectrometry proved inefficient.  Owing to the intrinsic concentration of 
gold in our available colloidal solutions (5% w/v), such instrumentation failed to detect 
for the analyte.
 While the aforementioned results failed to account for the presence of Au-NP 
within formed nanoparticle-protein complexes, information was obtained in regard to 
quantification techniques.  
 Examination of Cellular Uptake
 In both Phase I and Phase II of the cellular uptake protocols, we aimed to 
determine a centrifugation speed wherein Au-NPs remained suspended in solution while 
F87G cells were maximally collected.  Such would indicate a cellular uptake of Au-NPs 
versus a gravitational depression due to spinning conditions.
 Studies were performed using 50 nm and 10 nm Au-NPs.  As shown in Figures 19 
& 20, Au-NPs of the 50 nm diameter were maximally collected under conditions 
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optimized for F87G cell collection.  According to UV-Vis Spectrometry and GFAAS data, 
a maximal 9.52% of Au-NPs remained suspended in solution following centrifugation.  
Alternatively, a parallel study with 10 nm Au-NPs indicated a maximal 97.3% of Au-NPs 
remaining in solution following centrifugation.  Such results point toward the cellular 
uptake of Au-NPs into F87G cells rather than centrifugal suppression.
 Furthermore, the mass difference between Au-NPs and F87G bacterial cells is 
such that centrifugation would disallow a conclusion pointing toward simple adhesion.  If 
the cellular uptake of Au-NPs occurs then the mass of Au-NP containing cells will be, by 
default, greater.  As such, these cells can easily be separated out by gravitational force.  In 
determining the centrifugation condition that does not remove Au-NPs from the 
supernatant but rather a maximum amount of bacterial cells from solution, we have 
specified the optimal spinning speed for 10 nm Au-NPs that points toward uptake rather 
than gravitational effects in the presence of F87G cells.
 Having determined optimized centrifugation conditions for 10 nm Au-NPs, 
cellular uptake studies were first performed using bare Au-NPs.  As shown in Figure 23, 
there is a direct and dose-dependent uptake of Au-NPs by the F87G cell line.  Moreover, 
the F87G cell line can be said to have a high capacity for the uptake of colloidal gold 
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nanoparticles—at the highest dosing level, F87G cells are shown to ingest 894 ug / L of 
Au-NP.
 In an effort to explicate the role of plasma proteins in the uptake of Au-NPs and 
their ability, if any, to mediate cellular entry, studies were performed using BSA coated 
Au-NPs as cellular dosing material.  A number of variant protocols were performed—
molar ratios of BSA and Au-NP were manipulated; duplicate samples were prepared to 
test for precision; and cellular content, following an extended incubation period, was 
washed and resuspended in order to facilitate maximal Au-NP uptake.  Results from this 
study, as shown in Figure 25, indicate a suppression of Au-NP cellular uptake in the 
presence of bovine serum albumin plasma protein.
 
 In arriving at said reasoning, two sample sets of BSA:Au-NP were prepared and 
examined in terms of cellular uptake.  Sample set 1 was formulated using (x:1) molar 
ratios of plasma protein to Au-NP.  Sample set 2 was formulated using (x:2) molar ratios 
of plasma protein to Au-NP.  In each set, there is a significant decrease in Au-NP cellular 
uptake, indicating the inhibitory effects of BSA.
Future Directions
 
 Owing to the nature of results obtained for protein coated Au-NPs, future research 
efforts aim to examine the specific interactions had between Au-NPs and select plasma 
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proteins.  As is known, the nanoparticle-protein interface is yet to be fully understood and 
persists as a barrier in biological applications 2.  In turn, subsequent investigations 
propose to elucidate 1) the mechanism of Au-NP entry into the cell  2) optimal BSA:Au-
NP saturation levels for cellular uptake and 3) intrinsic binding affinities and / or kinetics 
of nanoparticle-protein complexation.  Results from these studies will help to expound 
data, as collected within this experiment, and provide information concerning optimal 
parameters in regard to cellular uptake and nanoparticle-protein interactions.
 In the interest of time, current work has involved the investigation of bovine 
serum albumin, known to be the most abundant amongst plasma proteins.  Subsequent 
studies, however, may prove additionally informative should protein identities be varied.  
Moreover, nanoparticle size and incubation periods can be manipulated so as to affect 
cellular uptake rates 25.  Proposed work, alongside the data collected within this study, 
will, in turn, continue to advance applications of nanomaterials while also elucidating 
their nature in complex biochemical systems. 
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